Observe Medical ASA announced that Biim AS has extended its agreement with Fresenius Medical Care for the supply of wireless pocketable ultrasound devices. The initial agreement with Fresenius was entered into in October 2021, with a one-year extension exercised in October 2023. This renewal extends the partnership for an additional two years, until April 1, 2026.

Under the agreement, Biim will continue to supply Fresenius with their wireless pocketable ultrasound devices for use in their dialysis clinics across the United States. As of May 31, 2024, Biim has successfully delivered 285 units in select Fresenius test clinics, positioning the Company for potential expansion to all approx. 3,000 US clinics.

This renewal strengthens Biim's position within the dialysis market and demonstrates continued confidence from a leading global healthcare provider like Fresenius.